MacroGenics, Inc. announced on October 30, 2024, that Scott Koenig, M.D., Ph.D., President and Chief Executive Officer, intends to step down from his role early next year. Dr. Koenig co-founded MacroGenics 24 years ago and has led the company since its inception.
The company's Board of Directors has initiated a search process to identify its next Chief Executive Officer, retaining Heidrick & Struggles for this purpose. A special committee of the Board has been established to oversee the transition process.
William Heiden, Chairman of the Board, stated that the company has a broad portfolio of promising assets and a strong balance sheet, making this the right time to transition to a new phase of leadership. Dr. Koenig will continue to support the company as an advisor and shareholder.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.